15th Aug 2016 06:48
LONDON (Alliance News) - A US court jury has decided animal genetics company Genus PLC is liable to pay damages to Inguran LLC, operating as Sexing Technologies, after infringing two of Inguran's patents and a confidentiality agreement.
On Friday, the US district court for the western district of Wisconsin found that the two patents held by Inguran were valid and infringed by Genus' sexed semen processing technology. The court also ruled Genus had breached its confidentiality obligations under the 2012 semen sorting agreement between the two parties.
The jury decided Genus should pay Inguran USD750,000 upfront and an ongoing royalty of USD1.25 per dose of semen for Genus' first patent infringement. Genus will pay another USD500,000 upfront and a USD0.50 per dose royalty for its second patent infringement.
Damages for Genus' breach of the confidentiality obligations under the 2012 semen sorting agreement were determined by the jury to be USD750,000.
Genus said it is now awaiting the court's decision on its request for an injunction, and is considering other post-verdict motions.
By Lucy Heming; [email protected]
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Genus